Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu

Psychotic Disorders

The division of psychotic disorders is interested in the social, psychological and genetic correlates of psychotic disorders and prodromal states as well as in the investigation of pharmacological and psychotherapeutic treatment options. Another field of interest is to explore the subjective, interpersonal and institutional aspects in the understanding and treatment of patients diagnosed with psychoses.

You are here:

Current projects comprise:

  • Early recognition and treatment of psychotic disorders: The centre for early recognition and treatment for psychotic disorders (FeTZ) focuses the neurobiological underpinnings of the early course of psychotic illness using brain imaging, electrophysiological and neuropsychological methods.
  • The investigation of the neurobiological, functional and genetic correlates of social cognitive and interpersonal processes in patients with psychoses and their relatives, and of the efficacy of psychotherapeutic treatment approaches targeting mentalising capacity and social interaction (research group "Empathy and interpersonal processes")
  • The investigation of the efficacy of psychotherapeutic treatments for patients with psychoses: An RCT regarding the effects of manualized, Modified Psychodynamic Psychotherapy for Schizophrenia (MPP-S study) is currently conducted by group "Empathy and interpersonal processes" in cooperation with Prof. Dr. med. Dorothea von Haebler, International Psychoanalytic University Berlin. Evidence for the efficacy of art therapy in acute psychotic episodes was supported by a pilot RCT (KUSS study, in cooperation with Prof. Dr. Karin Dannecker, Berlin Weissensee School of Art).
  • The basic-scientific investigation of predictors and endophenotypes in schizophrenia using brain imaging, electrophysiological and neuropsychological methods. Molecular genetic analyses focusing the effects and side-effects of antipsychotic drugs aim at the development of individualised pharmacological treatment options entailing lower risks for patients (Prof. Dr. med. Florian Schlagenhauf, AG Lernen und Kognition; PD Dr. med. Andres Neuhaus, Cognitive Neurophysiology Lab; Prof. Dr. med. Daniel Müller, Prof. Dr. med. Imke Puls, research group Empathie und interpersonelle Prozesse).
  • In the social psychiatric field, modern treatment approaches like ACT and hometreatment are currently evaluated with respect to patient-centered outcomes and efficiency (research group "Empathy and interpersonal processes").
  • Patients' subjective experience of coercive interventions in psychiatry and strategies their reduction are currently investigated in a government-financed, joint research project (ZVP-study) with the federal association Bundesarbeitsgemeinschaft Gemeindepsychiatrischer Verbünde e. V. (AG Empathie und interpersonelle Prozesse, AG Sozialpsychiatrie und Versorgungsforschung).

Heads of the research divsion Psychotic Disorders

Prof. Dr. med. Christiane Montag

Senior consultant, Head of research division Psychotic disorders, Head of research groups Empathy and interpersonal processes and Psychotherapy for Psychoses

Prof. Dr. med. Florian Schlagenhauf

Physician, Head of research division Psychotic Disorders, Head of research group Learning & Cognition

Dr. med. Martin Voss

Senior physician Soteria Berlin, Head of research division Psychotic disorders, Head of research group Phenomenological and Experimental Psychopathology

Standard-Porträt "Person, neutral"


Lasse Brandt
Anna-Lena Bröcker
Dr. med. André Ehrlich
Catharina Görtler
Dr. med. Bernhard Haslinger
Prof. Dr. med. Dorothea von Haebler
Sandra Just
Dr. med. Dipl.-Chem. Marion Lautenschlager
Dr. phil. Anja Lehmann
Ivan Nenchev
Frauke Stuke
Dr. med. Ines Theophil

Visiting scientists

Prof. Dr. med. Undine Lang
Prof. Dr. med. Daniel J. Müller
PD Dr. med. Andres Neuhaus
Prof. Dr. med. Imke Puls